A Study of HMPL-306 in Advanced Solid Tumors With IDH Mutations

Clinical trial NCT04762602 · TERMINATED

Trial details

NCT number: NCT04762602
Sponsor: Hutchmed
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Isocitrate Dehydrogenase Gene Mutation

Start date: 2021-02-28
Primary completion: 2025-02-27
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.